Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell Carcinoma

Open Access

Peer-reviewed

Research Article

Witold Wiecek,

Affiliation LASER Analytica, Halton House, 20–23 Holborn, London, EC1N 2JD, United Kingdom
⨯
Helene Karcher

* E-mail: Helene.Karcher@la-ser.com

Affiliation LASER Analytica, Halton House, 20–23 Holborn, London, EC1N 2JD, United Kingdom
⨯

Reader Comments (1)

Curve fitting
Is the Subject Area "Curve fitting" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Distribution curves
Is the Subject Area "Distribution curves" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Renal cell carcinoma
Is the Subject Area "Renal cell carcinoma" applicable to this article?

Thanks for your feedback.
Cancer detection and diagnosis
Is the Subject Area "Cancer detection and diagnosis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.